Search Results - Tiansuo Zhao

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Biological risk based on preoperative serum CA19‐9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcino... by Shaofei Chang, Yaohua Liu, Yuexiang Liang, Quan Man, Haorui Li, Yu Guo, Tiansuo Zhao

    Published in Cancer Reports (2023-12-01)
    Get full text
    Article


  2. 2

    An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers by Chungen Lan, Chungen Lan, Chungen Lan, Chungen Lan, Chungen Lan, Bo Ni, Bo Ni, Bo Ni, Tiansuo Zhao, Tiansuo Zhao, Tiansuo Zhao, Zekun Li, Zekun Li, Zekun Li, Junjin Wang, Junjin Wang, Junjin Wang, Ying Ma, Ying Ma, Ying Ma, Weidong Li, Weidong Li, Weidong Li, Weidong Li, Xiuchao Wang, Xiuchao Wang, Xiuchao Wang

    Published in Frontiers in Genetics (2022-05-01)
    Get full text
    Article


  3. 3

    Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study by Haorui Li, Yu Guo, Xugang Sun, Yang Lu, Shaofei Chang, Xiuchao Wang, Song Gao, Chuntao Gao, Tiansuo Zhao

    Published in Frontiers in Oncology (2023-10-01)
    Get full text
    Article


  4. 4

    Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer by Shengnan Li, Gengpu Zhang, Yang Lu, Tiansuo Zhao, Chuntao Gao, Weishuai Liu, Yongjun Piao, Yanan Chen, Chongbiao Huang, Antao Chang, Jihui Hao

    Published in Frontiers in Oncology (2022-02-01)
    Get full text
    Article


  5. 5

    Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms by Xiuchao Wang, Junjin Wang, Xi Wei, Lihui Zhao, Bo Ni, Zekun Li, Chuntao Gao, Song Gao, Tiansuo Zhao, Jian Wang, Weidong Ma, Xiao Hu, Jihui Hao

    Published in Cancer Biology & Medicine (2022-10-01)
    Get full text
    Article


  6. 6

    SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression. by Chuntao Gao, Shasha Li, Tiansuo Zhao, Jing Chen, He Ren, Huan Zhang, Xiuchao Wang, Mingxiao Lang, Jingcheng Liu, Song Gao, Xiao Zhao, Jun Sheng, Zhanna Yuan, Jihui Hao

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  7. 7

    Correction: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis by Chongbiao Huang, Hui Li, Yang Xu, Chao Xu, Huizhi Sun, Zengxun Li, Yi Ge, Hongwei Wang, Tiansuo Zhao, Song Gao, Xiuchao Wang, Shengyu Yang, Peiqing Sun, Zhe Liu, Jing Liu, Antao Chang, Jihui Hao

    Published in Signal Transduction and Targeted Therapy (2024-01-01)
    Get full text
    Article


  8. 8

    BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis by Chongbiao Huang, Hui Li, Yang Xu, Chao Xu, Huizhi Sun, Zengxun Li, Yi Ge, Hongwei Wang, Tiansuo Zhao, Song Gao, Xiuchao Wang, Shengyu Yang, Peiqing Sun, Zhe Liu, Jing Liu, Antao Chang, Jihui Hao

    Published in Signal Transduction and Targeted Therapy (2023-07-01)
    Get full text
    Article


  9. 9

    Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer by Xiaofan Guo, Yuxiao Liu, Tianchen Li, Xiaopeng An, Yuning Song, Peijun Xu, Jing Huang, Yiping Zou, Bohang Xu, Yongjie Xie, Zekun Li, Chenyang Meng, Tiansuo Zhao, Xiuchao Wang, Hongwei Wang, Chuntao Gao, Xuan Zhou, Jun Yu, Song Gao, Jihui Hao

    Published in Signal Transduction and Targeted Therapy (2026-04-01)
    Get full text
    Article


  10. 10

    Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma by Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yang Liu, Xiaoqing Ma, Jinsheng Ding, Shengyu Yang, Ran Zhao, Antao Chang, Chuntao Gao, Jing Liu, Tiansuo Zhao, Xiuchao Wang, Chongbiao Huang, Song Gao, Ying Ma, Bo Tang, Yukuan Feng, Hongwei Wang, Jihui Hao

    Published in Cancer Biology & Medicine (2023-08-01)
    Get full text
    Article


  11. 11

    Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis by Tianxing Zhou, Yongjie Xie, Xupeng Hou, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yifei Wang, Hongwei Wang, Wenna Jiang, Song Gao, Tiansuo Zhao, Antao Chang, Xiuchao Wang, Hongxia Sun, Xiufeng Zhang, Shengyu Yang, Chongbiao Huang, Jihui Hao, Jing Liu

    Get full text
    Article


Search Tools: